Protein Labeling Reagents
Cayman Chemical MyrIstIc AcId Alkyn 5mg
A form of the 14-carbon myristic acid with an ω-terminal alkyne group; can be used in linking reactions utilizing click chemistry
Medchemexpress LLC HY-D0921 5mg Medchemexpress, Heptamethine cyanine dye-1 CAS:162411-29-2 Purity:>98%
Medchemexpress, HY-D0921 5mg Heptamethine cyanine dye-1 CAS:162411-29-2 Heptamethine cyanine dye-1 is a near-infrared cyanine dye for fluorescence imaging in biological systems. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Biotium CD45 / LCA(136-4B5), CF640R conjugate, 0.1mg/mL
CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. This MAb reacts with all isoforms of CD45R expressed by all hematopoietic cells, except erythrocytes, having a higher level of expression on lymphocytes than on granulocytes (Workshop IV). Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplas
![eMolecules Broadpharm / Cy7 NHS ester / 1mg / 296213718 / BP-22538 / 95.000 / 1432019-64-1 / [null] / 733.660 / C41H48BF4N3O4](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502455003.PNG-250.jpg)
eMolecules Broadpharm / Cy7 NHS ester / 1mg / 296213718 / BP-22538 / 95.000 / 1432019-64-1 / [null] / 733.660 / C41H48BF4N3O4
Broadpharm / Cy7 NHS ester / 1mg / 296213718 / BP-22538 / 95.000 / 1432019-64-1 / [null] / 733.660 / C41H48BF4N3O4
Cayman Chemical MyrIstIc AcId Alkyn 1mg
A form of the 14-carbon myristic acid with an ω-terminal alkyne group; can be used in linking reactions utilizing click chemistry
(=O)=O)c3ccc4c(cc(cc4c3C2(C)C)S(O)(=O)=O)S(O)(=O)=O)\c2ccc(CCCCC(=O)ON3C(=O)CCC3=O)cc2)N(CCCS(O)(=O)=O)c2ccc3c(cc(cc3c12)S(O)(=O)=O)S(O)(=O)=O | 1mg | 713700011](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502462726.JPG-250.jpg)
eMolecules IR 680LT NHS ester | Broadpharm |1293.420 | C54H58N3O22S6 | 0.000 | CC1(C)\C(=C/C=C(/C=C/C2=[N](CCCS(O)(=O)=O)c3ccc4c(cc(cc4c3C2(C)C)S(O)(=O)=O)S(O)(=O)=O)\c2ccc(CCCCC(=O)ON3C(=O)CCC3=O)cc2)N(CCCS(O)(=O)=O)c2ccc3c(cc(cc3c12)S(O)(=O)=O)S(O)(=O)=O | 1mg | 713700011
IR 680LT NHS ester | Broadpharm |1293.420 | C54H58N3O22S6 | 0.000 | CC1(C)\C(=C/C=C(/C=C/C2=[N](CCCS(O)(=O)=O)c3ccc4c(cc(cc4c3C2(C)C)S(O)(=O)=O)S(O)(=O)=O)\c2ccc(CCCCC(=O)ON3C(=O)CCC3=O)cc2)N(CCCS(O)(=O)=O)c2ccc3c(cc(cc3c12)S(O)(=O)=O)S(O)(=O)=O | 1mg | 713700011
Biotium PLGF(PLGF93), CF488A conjugate, 0.1mg/mL
The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesio
Biotium CD74(LN-2), CF488A conjugate, 0.1mg/mL
This antibody recognizes a protein of ~35 kDa, identified as CD74 (Workshop IV). CD74 is a type II transmembrane protein which binds to the peptide binding groove of newly synthesized MHC class II alpha/beta heterodimers and prevents their premature association with endogenous polypeptides. CD74 is expressed primarily by antigen presenting cells, such as B-lymphocytes (from before the pre-B cell stage to before the plasma cell stage), macrophages, and monocytes, and many epithelial cells. Anti-CD74 stains predominantly germinal center lymphocytes and B-cell lymphomas, but rarely T-cell lymphomas. Anti-CD74 has been shown to be useful in differentiating atypical fibroxanthoma (-) from malignant fibrous histiocytoma ( ).Primary antibodies are available purified, or with a selection of fluorescent CF Dyes and other labels. CF Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF405S and CF405M are not recommended for detecti
Biotium CD33(C33/69), CF488A conjugate, 0.1mg/mL
Recognizes a 67 kDa glycoprotein, which is identified as CD33. It is a transmembrane protein of the sialic acid-binding immunoglobulin-like lectin (Siglec) family. It belongs to the immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing molecules able of recruiting protein tyrosine phosphatases SHP-1 and SHP-2 to signal assemblies; these ITIMs are also used for ubiquitin-mediated removal of the receptor from the cell surface. CD33 is expressed on cells of myelomonocytic lineage, binds sialic acid residues in N- and O-glycans on cell surfaces, and is a therapeutic target for acute myeloid leukemia. CD33 is expressed on myeloid progenitors, monocytes, granulocytes, dendritic cells and mast cells. It is absent on platelets, lymphocytes, erythrocytes and hematopoietic stem cells.Primary antibodies are available purified, or with a selection of fluorescent CF Dyes and other labels. CF Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluor
Biotium CD63 (Late Endosomes Marker)(LAMP3/2789), Biotin conjugate, 0.1mg/mL
This MAb recognizes protein of 26 kDa-60 kDa, which is identified as CD63. Its epitope is different from that of MAb LAMP3/529. The tetraspanins are integral membrane proteins expressed on cell surface and granular membranes of hematopoietic cells and are components of multi-molecular complexes with specific integrins. The tetraspanin CD63 is a lysosomal membrane glycoprotein that translocates to the plasma membrane after platelet activation. CD63 is expressed on activated platelets, monocytes and macrophages, and is weakly expressed on granulocytes, T cell and B cells. It is located on the basophilic granule membranes and on the plasma membranes of lymphocytes and granulocytes. CD63 is a member of the TM4 superfamily of leukocyte glycoproteins that includes CD9, CD37 and CD53, which contain four transmembrane regions. CD63 may play a role in phagocytic and intracellular lysosome-phagosome fusion events. CD63 deficiency is associated with Hermansky-Pudlak syndrome and is stro
Lumiprobe Cyanine7.5 NHS ester | 1469541-54-5 | 5 mg
Cyanine7.5 NHS ester | Purity: 95% | Mol Wt: 833.76 | 1469541-54-5 | 5 mg
Biotium PLGF(PLGF93), CF488A conjugate, 0.1mg/mL
The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesio